Capula Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-14,900	Closed	-$893K	–	327
2023 Q3	$893K	Buy	14,900 +7,080	+91%	+$424K	0.02%	105
2023 Q2	$564K	Buy	+7,820	New	+$564K	0.01%	121
2023 Q1	–	Sell	-11,640	Closed	-$778K	–	503
2022 Q4	$778K	Buy	+11,640	New	+$778K	0.01%	237